Status:
UNKNOWN
ORCA Study: Osteoarthritis and Risks Associated With the Consumption of NSAIDs
Lead Sponsor:
Scandinavia Pharma
Conditions:
Osteoarthritis
Eligibility:
All Genders
38+ years
Brief Summary
Cross-sectional epidemiological study in patients with diagnosis of osteoarthritis (OA) in order to evaluate risk factors associated with the use / prescription of non-steroidal anti-inflammatory drug...
Detailed Description
OBJECTIVE: To evaluate the presence of risk factors associated with the use / prescription of non-steroidal anti-inflammatory drugs (NSAID) in patients diagnosed with osteoarthritis (OA). MATERIALS A...
Eligibility Criteria
Inclusion
- Age ≥ 38 years
- Previous diagnosis of OSTEOARTRITIS (primary or secondary) at least 30 days before or more, in at least one or more of the following locations: Knee and / or Hip and / or Hand, according to criteria of the American College of Rheumatology (ACR)
Exclusion
- Refusal to participate in the study by the patient.
- Patients who, in the judgment of the Investigator, do not understand or are not willing to adequately answer to the questions.
- Mental or psychiatric illness that, in the judgment of the investigator, does not allow adequate information to be obtained.
Key Trial Info
Start Date :
June 10 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2024
Estimated Enrollment :
1250 Patients enrolled
Trial Details
Trial ID
NCT04099459
Start Date
June 10 2019
End Date
July 1 2024
Last Update
September 23 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Scandinavia Pharma
Bogotá, Colombia, 110111